0001209191-12-032056.txt : 20120604 0001209191-12-032056.hdr.sgml : 20120604 20120604180244 ACCESSION NUMBER: 0001209191-12-032056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120601 FILED AS OF DATE: 20120604 DATE AS OF CHANGE: 20120604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROE ROBERT L CENTRAL INDEX KEY: 0001286208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 12887187 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-06-01 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001286208 ROE ROBERT L C/O CORCEPT THERAPEUTICS 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 President and Secretary Common stock 2012-06-01 4 M 0 10000 1.19 A 10000 D Common stock 2012-06-01 4 S 0 10000 4.0623 D 0 D Stock option 1.19 2012-06-01 4 M 0 10000 0.00 D 2019-03-26 Common stock 10000 140000 D Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.05 to $4.07 per share. Full information on the numbers of shares sold at each sale price is available upon request. Fully exerciseable. s/s Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated, attorney-in-fact 2012-06-04